Cornerstone Capital Management Holdings’s West Pharmaceutical WST Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-56,046	Closed	-$5.39M	–	1331
2017 Q3	$5.39M	Buy	56,046 +47,246	+537%	+$4.27M	0.04%	410
2017 Q2	$831K	Buy	+8,800	New	+$809K	0.01%	947
2016 Q3	–	Sell	-4,233	Closed	-$321K	–	1469
2016 Q2	$321K	Sell	4,233 -8,900	-68%	-$648K	﹤0.01%	1120
2016 Q1	$910K	Hold	13,133	–	–	0.01%	929
2015 Q4	$791K	Buy	+13,133	New	+$790K	0.01%	948
2014 Q2	–	Sell	-7,050	Closed	-$311K	–	1408
2014 Q1	$311K	Sell	7,050 -41,492	-85%	-$1.95M	﹤0.01%	1051
2013 Q4	$2.38M	Sell	48,542 -8,200	-14%	-$384K	0.03%	608
2013 Q3	$2.33M	Sell	56,742 -6,200	-10%	-$237K	0.03%	599
2013 Q2	$2.21M	Buy	+62,942	New	+$2.07M	0.03%	615

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Cornerstone Capital Management Holdings's WST Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of West Pharmaceutical (WST) in Q4 2017, closing a stake of 56,046 shares — an estimated $5.39M sold.

Cornerstone Capital Management Holdings first reported a position in WST in Q2 2013 and held it in 9 quarters. The position peaked at $5.39M in Q3 2017. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

Cornerstone Capital Management Holdings reported no remaining West Pharmaceutical position as of Q4 2017 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 56,046 West Pharmaceutical shares in Q4 2017, an estimated $5.39M.
Cornerstone Capital Management Holdings first reported a position in West Pharmaceutical in Q2 2013 and held it in 9 quarters.
Cornerstone Capital Management Holdings's West Pharmaceutical position peaked at $5.39M in Q3 2017.
338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.